AGTC Is Excited To Announce Seasoned Healthcare Financial and Operations Executive Jonathan I. Lieber As Their New Chief Financial Officer
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, announced Jonathan I. Lieber as their new Chief Financial Officer.
“We are thrilled to welcome Jonathan Lieber to the AGTC team,” said Sue Washer, President and CEO of AGTC. “He’s a seasoned financial and operations executive with valuable experience in the healthcare sector, making him a great addition to the AGTC team. We are excited to see his strategic perspective and apply it to our operational planning.”
Mr. Lieber brings 30 years of experience as a both CFO for emerging growth public and private life sciences companies and an investment banker. In his role as a CFO, Mr. Lieber has led numerous capital raises and had responsibility for financial reporting and regulatory compliance. He has developed relationships with investors and provided strategic counsel to C-suite executives and Boards of Directors to support strategic planning, business development, and investor relations activities.
Learn more about AGTC Is Excited To Announce Seasoned Healthcare Financial and Operations Executive Jonathan I. Lieber As Their New Chief Financial Officer.